US Broker Ratings

Humana Inc. (HUM) Stock Analysis: Exploring a 28% Potential Upside Amidst Strong Revenue Growth

Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans sector, presents an intriguing opportunity for investors, highlighted by a potential upside of 28.25% according to analyst ratings. As..

Elanco Animal Health (ELAN) Stock Analysis: A 25% Upside in the Dynamic Animal Health Market

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a formidable player in the healthcare sector, particularly within the niche of drug manufacturing for both specialty and generic animal health products...

BioNTech SE (BNTX) Stock Analysis: Unpacking the 42.60% Potential Upside and Market Dynamics

BioNTech SE (BNTX), a prominent player in the biotechnology sector, has recently captured investor attention with a notable potential upside of 42.60%, as indicated by its average target price of..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Strong Upside Potential with Robust Revenue Growth

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, offers an intriguing opportunity for investors looking for high growth potential in the healthcare industry. With a current..

RadNet, Inc. (RDNT) Stock Analysis: Healthcare Innovator with Nearly 49% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a key player in the healthcare sector’s diagnostics and research industry, is captivating investor attention with its expansive growth potential, underscored by a remarkable 48.78% upside..

Corcept Therapeutics (CORT) Stock Analysis: Exploring the 103% Potential Upside in Biotech Innovation

Corcept Therapeutics Incorporated (NASDAQ: CORT) is drawing attention from investors with its robust performance metrics and a striking potential upside of 103.42%. As a key player in the biotechnology industry,..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Strong Buy with a 14% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) continues to capture investor attention with its robust portfolio of diagnostic and therapeutic products aimed at enhancing the detection and treatment of significant health issues..

GE HealthCare Technologies Inc. (GEHC): Analyst Consensus Points to Significant 31.48% Upside Potential

GE HealthCare Technologies Inc. (GEHC), a key player in the healthcare sector, stands at the forefront of the medical devices industry, drawing investor attention with its promising growth prospects. With..

BrightSpring Health Services, I (BTSG)

⚠️ No article content returned.

..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Promising Biotech Play with 32.74% Potential Upside

For investors with an eye on the biotechnology sector, Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents a compelling opportunity. With a market capitalization of $7.51 billion, this innovative company is making..

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech Gem with 69% Upside Potential

ADMA Biologics Inc (NASDAQ: ADMA), a burgeoning player in the biotech sector, has caught the attention of investors with its promising growth trajectory and significant upside potential. Headquartered in Ramsey,..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring a 28.69% Potential Upside in the Innovative Medical Devices Sector

TransMedics Group, Inc. (NASDAQ: TMDX), a prominent player in the medical devices industry, is captivating investor interest with its cutting-edge solutions in organ transplant therapy. With a market capitalization of..

Cardinal Health, Inc. (CAH)

⚠️ No article content returned.

..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a Promising 171.90% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a dynamic player in the biotechnology sector, is catching the eye of investors with an impressive potential upside of 171.90%. As a commercial-stage biopharmaceutical company,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unveiling a 23.29% Upside Potential in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (BIO), a prominent player in the healthcare sector specializing in medical devices, is drawing significant attention from investors with its promising upside potential. Headquartered in Hercules, California,..

Glaukos Corporation (GKOS) Stock Analysis: Exploring a 38.93% Potential Upside

Glaukos Corporation (NYSE: GKOS) has emerged as a notable player in the healthcare sector, specifically within the medical devices industry. Based in Aliso Viejo, California, this ophthalmic pharmaceutical and medical..

Medtronic plc (MDT) Stock Analysis: Navigating a 27.82% Potential Upside

For individual investors with an eye on the healthcare sector, Medtronic plc (NYSE: MDT) presents a compelling opportunity amidst the dynamic medical devices industry. Headquartered in Galway, Ireland, and boasting..

Royalty Pharma plc (RPRX) Stock Analysis: A Robust Biopharma Royalty Player with a Potential 12.94% Upside

Royalty Pharma plc (NASDAQ: RPRX) is a compelling player in the biopharmaceutical industry, strategically positioned as a major buyer of biopharmaceutical royalties and a financier of innovation. With a market..

Nuvalent, Inc. (NUVL) Stock Analysis: Riding High on Analyst Confidence with 46.98% Upside Potential

Nuvalent, Inc. (NASDAQ: NUVL) is making waves in the biotechnology sector, capturing investor attention with its ambitious pursuit of innovative cancer therapies and a remarkable 46.98% potential upside. As a..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A Compelling 86.73% Potential Upside in the Medical Device Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is positioned as a noteworthy player in the healthcare sector, particularly within the medical devices industry. The company specializes in digital healthcare solutions, with a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds